Cargando…
DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1
Bladder cancer is one of the most commonly diagnosed malignant tumors in the urinary system and causes a massive cancer-related death. DEPDC1B is a DEP domain-containing protein that has been found to be associated with a variety of human cancers. This study aimed to explore the role and mechanism o...
Autores principales: | Lai, Chin-Hui, Xu, Kexin, Zhou, Jianhua, Wang, Mingrui, Zhang, Weiyu, Liu, Xianhui, Xiong, Jie, Wang, Tao, Wang, Qi, Wang, Huanrui, Xu, Tao, Hu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672062/ https://www.ncbi.nlm.nih.gov/pubmed/33203836 http://dx.doi.org/10.1038/s41419-020-03190-6 |
Ejemplares similares
-
ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
por: Wang, Yuchen, et al.
Publicado: (2021) -
Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma
por: Liu, Xianhui, et al.
Publicado: (2020) -
Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022) -
Anti-GABAB receptor antibodies with autoimmune encephalitis in clear cell renal cell carcinoma: a case report
por: Wang, Huanrui, et al.
Publicado: (2021) -
Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021)